Andrews JD - Search Results

1

Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI.

Barlic J, Andrews JD, Kelvin AA, Bosinger SE, DeVries ME, Xu L, Dobransky T, Feldman RD, Ferguson SS, Kelvin DJ. Barlic J, et al. Among authors: andrews jd. Nat Immunol. 2000 Sep;1(3):227-33. doi: 10.1038/79767. Nat Immunol. 2000. PMID: 10973280

2

beta-arrestins regulate interleukin-8-induced CXCR1 internalization.

Barlic J, Khandaker MH, Mahon E, Andrews J, DeVries ME, Mitchell GB, Rahimpour R, Tan CM, Ferguson SS, Kelvin DJ. Barlic J, et al. J Biol Chem. 1999 Jun 4;274(23):16287-94. doi: 10.1074/jbc.274.23.16287. J Biol Chem. 1999. PMID: 10347185 Free article.

3

Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.

Khandaker MH, Mitchell G, Xu L, Andrews JD, Singh R, Leung H, Madrenas J, Ferguson SS, Feldman RD, Kelvin DJ. Khandaker MH, et al. Among authors: andrews jd. Blood. 1999 Apr 1;93(7):2173-85. Blood. 1999. PMID: 10090924 Free article.

4

Regulation of CCR2 chemokine receptor mRNA stability.

Xu L, Rahimpour R, Ran L, Kong C, Biragyn A, Andrews J, Devries M, Wang JM, Kelvin DJ. Xu L, et al. J Leukoc Biol. 1997 Nov;62(5):653-60. doi: 10.1002/jlb.62.5.653. J Leukoc Biol. 1997. PMID: 9365120

5

The impact of blunted beta-adrenergic responsiveness on growth regulatory pathways in hypertension.

Gros R, Ding Q, Chorazyczewski J, Andrews J, Pickering JG, Hegele RA, Feldman RD. Gros R, et al. Mol Pharmacol. 2006 Jan;69(1):317-27. doi: 10.1124/mol.105.013953. Epub 2005 Oct 13. Mol Pharmacol. 2006. PMID: 16223959

6

Site and sequence specific DNA methylation in the neurofibromatosis (NF1) gene includes C5839T: the site of the recurrent substitution mutation in exon 31.

Andrews JD, Mancini DN, Singh SM, Rodenhiser DI. Andrews JD, et al. Hum Mol Genet. 1996 Apr;5(4):503-7. doi: 10.1093/hmg/5.4.503. Hum Mol Genet. 1996. PMID: 8845843

7

DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.

Sadikovic B, Andrews J, Rodenhiser DI. Sadikovic B, et al. Toxicol Appl Pharmacol. 2007 Dec 15;225(3):300-9. doi: 10.1016/j.taap.2007.08.013. Epub 2007 Aug 23. Toxicol Appl Pharmacol. 2007. PMID: 17904174

8

Homonucleotide tracts, short repeats and CpG/CpNpG motifs are frequent sites for heterogeneous mutations in the neurofibromatosis type 1 (NF1) tumour-suppressor gene.

Rodenhiser DI, Andrews JD, Mancini DN, Jung JH, Singh SM. Rodenhiser DI, et al. Among authors: andrews jd. Mutat Res. 1997 Feb 3;373(2):185-95. doi: 10.1016/s0027-5107(96)00171-6. Mutat Res. 1997. PMID: 9042399

9

A five-basepair deletion (7118 delTTTTA) identified within neurofibromatosis (NF1) exon 39.

Rodenhiser DI, Jung JH, Gillett JM, Hovland K, Andrews J, Ainsworth PJ, Coulter-Mackie M, Singh SM. Rodenhiser DI, et al. Hum Mutat. 1997;9(5):473. doi: 10.1002/(SICI)1098-1004(1997)9:5<473::AID-HUMU15>3.0.CO;2-#. Hum Mutat. 1997. PMID: 9143929 No abstract available.

10

Heterogenous point mutations in the BRCA1 breast cancer susceptibility gene occur in high frequency at the site of homonucleotide tracts, short repeats and methylatable CpG/CpNpG motifs.

Rodenhiser D, Chakraborty P, Andrews J, Ainsworth P, Mancini D, Lopes E, Singh S. Rodenhiser D, et al. Oncogene. 1996 Jun 20;12(12):2623-9. Oncogene. 1996. PMID: 8700521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters